HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

COVID-19 in Individuals Treated With Long-Term Hydroxychloroquine: A Propensity Score-Matched Analysis of Cicatricial Alopecia Patients.

Abstract
Early in the COVID-19 pandemic, anti-malarial agent hydroxychloroquine (HCQ) was touted as a potentially effective COVID-19 treatment due to its purported antiinflammatory and antiviral effects.
AuthorsKatharina S Shaw, Lu Yin, Jinal K Shah, Rachel A Sally, Katerina S Svigos, Prince U Adotama, Hsiao Han Tuan, Jerry Shapiro, Rebecca A Betensky, Kristen I Lo Siccoa
JournalJournal of drugs in dermatology : JDD (J Drugs Dermatol) Vol. 20 Issue 8 Pg. 914-916 (Aug 01 2021) ISSN: 1545-9616 [Print] United States
PMID34397203 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Hydroxychloroquine
Topics
  • Alopecia (diagnosis, drug therapy)
  • Antiviral Agents (therapeutic use)
  • Cicatrix
  • Humans
  • Hydroxychloroquine (therapeutic use)
  • Pandemics
  • Propensity Score
  • Treatment Outcome
  • COVID-19 Drug Treatment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: